Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 94,973 | 36,230 | 9,435 | 58,107 |
| Marketable Securities | 75,000 | 30,000 | 30,000 | N/A |
| Receivables | 1,761 | 1,648 | 538 | 424 |
| TOTAL | $174,140 | $70,901 | $40,624 | $59,580 |
| Non-Current Assets | ||||
| PPE Net | 8 | 33 | 38 | 45 |
| Investments And Advances | 0 | 75,000 | 0 | 0 |
| Intangibles | 1,658 | 1,715 | 895 | 1,032 |
| Other Non-Current Assets | 1,039 | 776 | 0 | 0 |
| TOTAL | $2,705 | $77,524 | $933 | $1,077 |
| Total Assets | $176,844 | $148,425 | $41,557 | $60,657 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 12,412 | 6,719 | 4,522 | 4,010 |
| TOTAL | $12,412 | $6,719 | $4,524 | $4,010 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 185,706 | 147,981 |
| TOTAL | $N/A | $N/A | $185,706 | $147,981 |
| Total Liabilities | $12,412 | $6,719 | $190,229 | $151,992 |
| Shareholders' Equity | ||||
| Common Shares | 306,557 | 230,660 | 272 | 272 |
| Retained earnings | -149,739 | -91,612 | -149,443 | -91,931 |
| TOTAL | $164,432 | $141,707 | $-148,672 | $-91,335 |
| Total Liabilities And Equity | $176,844 | $148,425 | $41,557 | $60,657 |